|
Source
|
Web search phys.org/news/2020-07-tiny-mineral-part… |
|
Organization
|
University of Wisconin-Madison |
|
Website URL
|
sahalab.bme.wisc.edu |
|
Market status
|
Early Stage Concept |
|
Industry
|
Medical |
|
Value chain stage
|
Platform |
|
Business models
|
B2B |
|
Biotech components
|
Gene Editing |
|
Organization type(s)
|
University |
|
Funding types
|
University |
|
Notes
|
“University of Wisconsin–Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination—including a COVID-19 vaccine from Moderna Therapeutics that has advanced to clinical trials with humans. The technology relies on inserting into cells pieces of carefully designed messenger RNA (mRNA), a strip of genetic material that human cells typically transcribe from a person's DNA in order to make useful proteins and go about their business. Problems delivering mRNA safely and intact without running afoul of the immune system have held back mRNA-based therapy, but UW–Madison researchers are making tiny balls of minerals that appear to do the trick in mice." |
Added 3 years ago
Last modified 3 years ago
